Catherine Day (biochemist)

Last updated

Catherine Day
Catherine L. Day MS-5249-1387 (cropped).JPG
Day in 2012
Alma mater Massey University
Scientific career
Thesis

Catherine Louise Day is a New Zealand biochemist. She is currently a professor and was the head of the biochemistry department at the University of Otago. [1]

Contents

Career

After a BSc at Massey University, Day completed a PhD entitled Expression and characterisation of the n-terminal half of human lactoferrin in 1993, [2] also at Massey, before moving to the University of Otago where she rose to professor and head of department. [1]

She has received funding from the Health Research Council of New Zealand [3] [4] and Genesis Oncology Trust [5] and is an associate editor for biochemistry and biophysics of the Royal Society's Open Science Journal. [6]

Awards

Day won the Otago School of Medical Sciences' top award for 2010. [4]

Selected works

References

  1. 1 2 "Profile, Department of Biochemistry, University of Otago, New Zealand". Otago.ac.nz. Retrieved 16 December 2017.
  2. ↑ Day, Catherine (1993). Expression and characterisation of the n-terminal half of human lactoferrin (Doctoral thesis). Massey Research Online, Massey University. hdl:10179/4125.
  3. ↑ "Professor Catherine Day | Health Research Council". Hrc.govt.nz. Retrieved 16 December 2017.
  4. 1 2 Rudd, Allison (4 February 2011). "School of medical sciences names researcher of year". Otago Daily Times . Retrieved 10 August 2024.
  5. ↑ "Monday 4 December 2017, Otago researchers gain new insights into inflammatory signalling mechanisms implicated in cancer, News and events, Department of Biochemistry, University of Otago, New Zealand". Otago.ac.nz. 4 December 2017. Retrieved 16 December 2017.
  6. ↑ "Biochemistry and Biophysics | Open Science". Rsos.royalsocietypublishing.org. Archived from the original on 16 December 2017. Retrieved 16 December 2017.
  7. ↑ Chen, Lin; Willis, Simon N.; Wei, Andrew; Smith, Brian J.; Fletcher, Jamie I.; Hinds, Mark G.; Colman, Peter M.; Day, Catherine L.; Adams, Jerry M.; Huang, David C. S. (4 February 2005). "Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function". Molecular Cell. 17 (3): 393–403. doi: 10.1016/j.molcel.2004.12.030 . ISSN   1097-2765. PMID   15694340.
  8. ↑ van Delft, Mark F.; Wei, Andrew H.; Mason, Kylie D.; Vandenberg, Cassandra J.; Chen, Lin; Czabotar, Peter E.; Willis, Simon N.; Scott, Clare L.; Day, Catherine L.; Cory, Suzanne; Adams, Jerry M. (November 2006). "The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized". Cancer Cell. 10 (5): 389–399. doi:10.1016/j.ccr.2006.08.027. ISSN   1535-6108. PMC   2953559 . PMID   17097561.
  9. ↑ Verhagen, Anne M.; Silke, John; Ekert, Paul G.; Pakusch, Miha; Kaufmann, Hitto; Connolly, Lisa M.; Day, Catherine L.; Tikoo, Anjali; Burke, Richard; Wrobel, Carolyn; Moritz, Robert L. (4 January 2002). "HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins". The Journal of Biological Chemistry. 277 (1): 445–454. doi: 10.1074/jbc.M109891200 . ISSN   0021-9258. PMID   11604410.
  10. ↑ Czabotar, Peter E.; Lee, Erinna F.; van Delft, Mark F.; Day, Catherine L.; Smith, Brian J.; Huang, David C. S.; Fairlie, W. Douglas; Hinds, Mark G.; Colman, Peter M. (10 April 2007). "Structural insights into the degradation of Mcl-1 induced by BH3 domains". Proceedings of the National Academy of Sciences of the United States of America. 104 (15): 6217–6222. Bibcode:2007PNAS..104.6217C. doi: 10.1073/pnas.0701297104 . ISSN   0027-8424. PMC   1851040 . PMID   17389404.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.